课题基金 / 基金详情

Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER

Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER
CHARTER 中的生物心理社会表型和潜在机制
批准号:
10706855
负责人:
RONALD J. ELLIS
金额:
$4.07万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-12-08 至 2025-10-31

项目摘要

项目成果

RONALD J. ELLIS的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
PROJECT SUMMARY People with HIV (PWH) experience a diverse set of CNS complications including cognitive and mood disorders. CNS complications may occur even in individuals taking antiretroviral therapy (ART) to suppress HIV RNA, moreover, recent studies suggest HIV infection may accelerate aging among PWH. However, accelerated aging has not been carefully examined in the context of brain structure and may be complicated by the diversity in CNS complications among PWH. Studies based on magnetic resonance imaging (MRI) show a relationship between accelerated biological aging and accelerated brain atrophy. The proposed study aims to calculate “brain age”, which is a marker of biological aging estimated from structural neuroimaging variables, including cortical thickness and subcortical volume. Estimated brain age found to be greater than an individual’s chronological age is thought to reflect an accumulation of age-related changes to the brain. To better characterize the mechanisms of central nervous system (CNS) biotypes in people with HIV (PWH), the proposed supplement aims to extract cortical thickness and subcortical volume measures derived from MRI scans to compare estimated brain age to chronological age, telomere length and mitochondrial DNA copy numbers (biological markers of aging). The project is leveraged through the parent proposal (R01MH12520- 02), which will use clustering methods to assess CNS biotypes in PWH. Supplement Specific Aim 1 is to estimate brain age in the cohort using a composite measure of cortical thickness and subcortical volume to compare it to chronological age and biomarkers of biological aging. We propose to use a Least Absolute Shrinkage and Selection Operator (LASSO) regression to derive brain age, a method that works well with limited sample sizes. We hypothesize that cortices will be thinner (consistent with older brain age) among PWH who have adverse CNS biotypes when compared to the reference group of PWH who perform as expected on assessments of cognition, mood, and daily functioning. Supplement Specific Aim 2 is to determine how brain age relates to different CNS biotypes identified by machine learning in the parent project and how brain age relates to historical HIV-Associated Neurocognitive Disorders diagnosis. We will include health-related variables as covariates in the model, since they are associated with cognitive decline and older brain age. For example, cardiovascular risk factors, high levels of alcohol intake, and stroke risk score are associated with brain aging. We also hypothesize that estimated brain age will be accelerated among PWH with adverse CNS biotypes compared to the reference group of PWH. Disentangling the cognitive and biological effects of HIV in older adults and their relation to mental health will advance the HIV field through informing our understanding of mental health conditions among people with HIV. This proposed diversity supplement will provide the applicant with critical training in neuroimaging, machine learning, telomere and mitochondrial DNA count research, which will broaden her research skillset and understanding of neurobiological mechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GPLD1: Association with Cognition and Amelioration through Exercise in Aging People with HIV
CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan
GPLD1: Association with Cognition and Amelioration through Exercise in Aging People with HIV
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: